Company Builder In Biotech -
With A Different DNA.

We Consider Ourselves An
Expanded Part Of Your Team.

Come and talk to us if you are a biotech entrepreneur in Europe or about to set-up your biotech company in Europe with great ambitions and well-differentiated, ground-breaking programs.

FORTY51 Ventures Is A
Biotech Venture Creator

Company Building

We invest in European early stage biotech opportunities with a clear path to the clinic, whether single-asset or platform. FORTY51 Ventures is the first institutional investor in your biotech company.

First or Best in Class

We bring decades of experience in the pharma industry and support entrepreneurs in their journey of venture creation.


We are therapeutic area agnostic with a preference for CNS, oncology, immunology and inflammation, fibrotic disorders and optha.

Our Story

FORTY51 Ventures was founded in April 2022 as company builder and early stage investor of exceptional biotech companies in Europe with first or best-in-class potential. We source and incubate locally, and mature companies globally.

Our vast and deep experience allows us to support entrepreneurs and be involved hands-on to build stronger companies faster.

Let's Get To Know One Another

Together with you we build stronger companies.
We look forward to receiving your message and meet you in 4051 Basel

Sascha Oliver Bucher

Sara Núñez-García

Tamás Schweighoffer